DICLAC

This brand name is authorized in Brazil, Cyprus, Germany, Estonia, Croatia, Ireland, Lithuania, Malta, Poland, Romania

Active ingredients

The drug DICLAC contains one active pharmaceutical ingredient (API):

1 Diclofenac
UNII QTG126297Q - DICLOFENAC SODIUM

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.

Read about Diclofenac

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DICLAC Solution for injection Υπουργείο Υγείας (CY) MPI, EU: SmPC
DICLAC Enteric-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M01AB05 Diclofenac M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 511503102110411
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 03223108, 03223120, 03223166, 03223172, 03223189, 03223195, 03223203, 03223226, 03424835, 03424841, 05388026, 06339969, 06339975, 07238940, 07238957, 07238992, 07239000, 07577211, 07577228, 12605263
Country: EE Ravimiamet Identifier(s): 1012307, 1040331, 1040342, 1040353, 1040364, 1071908, 1071920, 1071942, 1071964, 1071986, 1073999, 1078163, 1078174, 1153257, 1153268, 1185690, 1762679, 1762680, 1790737, 1880489
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-663384318
Country: IE Health Products Regulatory Authority Identifier(s): 20117, 22217, 22233, 22241, 22259, 22274, 34890
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1002550, 1002551, 1002556, 1002557, 1002559, 1003647, 1003648, 1014204, 1014205, 1015354, 1015355, 1020218, 1020219, 1020220
Country: MT Medicines Authority Identifier(s): AA1316/00401, AA1316/00402
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100075118, 100079317, 100086990, 100087009, 100109870, 100109886, 100121456, 100264173, 100354338, 100387533, 100418334, 100418860, 100433730, 100436473, 100439773, 100443527, 100447318, 100450916, 100450923, 100454080, 100457310, 100463575, 100463700, 100463718, 100464702
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W06822001, W06822002, W41807001, W41807002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.